Growth Metrics

ENDRA Life Sciences (NDRA) Depreciation and Depletion (2016 - 2025)

ENDRA Life Sciences has reported Depreciation and Depletion over the past 6 years, most recently at $21261.0 for Q4 2021.

  • Quarterly Depreciation and Depletion fell 33.31% to $21261.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $116238.0 through Dec 2021, down 18.48% year-over-year, with the annual reading at $44045.0 for FY2025, 5.26% down from the prior year.
  • Depreciation and Depletion was $21261.0 for Q4 2021 at ENDRA Life Sciences, down from $29823.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $45114.0 in Q3 2020 and troughed at $14865.0 in Q2 2018.
  • The 5-year median for Depreciation and Depletion is $20091.0 (2018), against an average of $23460.2.
  • Year-over-year, Depreciation and Depletion surged 126.37% in 2020 and then crashed 33.89% in 2021.
  • A 5-year view of Depreciation and Depletion shows it stood at $15360.0 in 2017, then skyrocketed by 30.66% to $20070.0 in 2018, then rose by 4.16% to $20904.0 in 2019, then soared by 52.5% to $31878.0 in 2020, then plummeted by 33.31% to $21261.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Depreciation and Depletion are $21261.0 (Q4 2021), $29823.0 (Q3 2021), and $33729.0 (Q2 2021).